Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2018, Article ID 1956403, 7 pages
https://doi.org/10.1155/2018/1956403
Review Article

The Role of Immune Defects and Colonization of Staphylococcus aureus in the Pathogenesis of Atopic Dermatitis

1Department of Dermatology, Venereology, and Allergology, Wroclaw Medical University, Wrocław, Poland
2Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, Lublin, Poland

Correspondence should be addressed to Danuta Nowicka; lp.corw.demu@akciwon.atunad

Received 3 February 2018; Accepted 19 February 2018; Published 2 May 2018

Academic Editor: Madhyastha Harishkumar

Copyright © 2018 Danuta Nowicka and Ewelina Grywalska. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Rajka, Essential Aspects of Atopic Dermatitis, Springer Berlin Heidelberg, Berlin, Heidelberg, 1989. View at Publisher · View at Google Scholar
  2. D. Wallach and A. Taieb, “Atopic dermatitis/atopic eczema,” Chemical Immunology and Allergy, vol. 100, pp. 81–96, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Tilles, D. Wallach, and A. Taieb, “Topical therapy of atopic dermatitis: controversies from Hippocrates to topical immunomodulators,” Journal of the American Academy of Dermatology, vol. 56, no. 2, pp. 295–301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. P. Dizon, A. M. Yu, R. K. Singh et al., “Systematic review of atopic dermatitis disease definition in studies using routinely-collected health data,” British Journal of Dermatology, 2018. View at Publisher · View at Google Scholar
  5. J. de Wit, J. E. E. Totté, F. J. M. van Buchem, and S. G. M. A. Pasmans, “The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis,” British Journal of Dermatology, 2017. View at Publisher · View at Google Scholar
  6. J. E. E. Totté, W. T. van der Feltz, M. Hennekam, A. van Belkum, E. J. van Zuuren, and S. G. M. A. Pasmans, “Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis,” The British Journal of Dermatology, vol. 175, no. 4, pp. 687–695, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Benenson, O. Zimhony, D. Dahan et al., “Atopic dermatitis—a risk factor for invasive Staphylococcus aureus infections: two cases and review,” The American Journal of Medicine, vol. 118, no. 9, pp. 1048–1051, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. B. S. Baker, “The role of microorganisms in atopic dermatitis,” Clinical and Experimental Immunology, vol. 144, no. 1, pp. 1–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. S. Lee, I. H. Oh, S. H. Choi, and Y. H. Rha, “Analysis of epidemiology and risk factors of atopic dermatitis in Korean children and adolescents from the 2010 Korean National Health and Nutrition Examination Survey,” BioMed Research International, vol. 2017, Article ID 5142754, 6 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. L. F. Eichenfield, W. L. Tom, S. L. Chamlin et al., “Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis,” Journal of the American Academy of Dermatology, vol. 70, no. 2, pp. 338–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Weidinger and N. Novak, “Atopic dermatitis,” Lancet, vol. 387, no. 10023, pp. 1109–1122, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Czarnowicki, J. G. Krueger, and E. Guttman-Yassky, “Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications,” The Journal of Allergy and Clinical Immunology In Practice, vol. 2, no. 4, pp. 371–379, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Agrawal and J. A. Woodfolk, “Skin barrier defects in atopic dermatitis,” Current Allergy and Asthma Reports, vol. 14, no. 5, p. 433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Le Lamer, L. Pellerin, M. Reynier et al., “Defects of corneocyte structural proteins and epidermal barrier in atopic dermatitis,” Biological Chemistry, vol. 396, no. 11, pp. 1163–1179, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Jungersted, H. Scheer, M. Mempel et al., “Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema,” Allergy, vol. 65, no. 7, pp. 911–918, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kezic and I. Jakasa, “Filaggrin and skin barrier function,” Current Problems in Dermatology, vol. 49, pp. 1–7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Chan, W. Terry, H. Zhang et al., “Filaggrin mutations increase allergic airway disease in childhood and adolescence through interactions with eczema and aeroallergen sensitization,” Clinical & Experimental Allergy, vol. 48, no. 2, pp. 147–155, 2018. View at Publisher · View at Google Scholar
  18. A. Ogrodowczyk, L. Markiewicz, and B. Wróblewska, “Mutations in the filaggrin gene and food allergy,” Gastroenterology Review, vol. 4, no. 4, pp. 200–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Candi, R. Schmidt, and G. Melino, “The cornified envelope: a model of cell death in the skin,” Nature Reviews Molecular Cell Biology, vol. 6, no. 4, pp. 328–340, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. K. L. Hon and A. K. C. Leung, “Use of ceramides and related products for childhood-onset eczema,” Recent Patents on Inflammation & Allergy Drug Discovery, vol. 7, no. 1, pp. 12–19, 2013. View at Publisher · View at Google Scholar
  21. P. K. Elias, M. F. Elias, R. B. D’Agostino, L. M. Sullivan, and P. A. Wolf, “Serum cholesterol and cognitive performance in the Framingham Heart Study,” Psychosomatic Medicine, vol. 67, no. 1, pp. 24–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Proksch, R. Folster-Holst, and J. M. Jensen, “Skin barrier function, epidermal proliferation and differentiation in eczema,” Journal of Dermatological Science, vol. 43, no. 3, pp. 159–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. P. B. Heczko, A. Kasprowicz, and J. Kucharczyk, “Carrier state of Staphylococcus aureus. Susceptibility to free fatty acids of the representatives of the flora from the human nasal cavity,” Medycyna Doświadczalna i Mikrobiologia, vol. 23, no. 3, pp. 205–210, 1971. View at Google Scholar
  24. A. Heratizadeh, “Atopic dermatitis: new evidence on the role of allergic inflammation,” Current Opinion in Allergy and Clinical Immunology, vol. 16, no. 5, pp. 458–464, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. K. B. Yarbrough, K. J. Neuhaus, and E. L. Simpson, “The effects of treatment on itch in atopic dermatitis,” Dermatologic Therapy, vol. 26, no. 2, pp. 110–119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. T. Elliott and J. M. Hanifin, “Delayed cutaneous hypersensitivity and lymphocyte transformation: dissociation in atopic dermatitis,” Archives of Dermatology, vol. 115, no. 1, pp. 36–39, 1979. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Chan, W. R. Henderson Jr, S. H. Li, and J. M. Hanifin, “Prostaglandin E2 control of T cell cytokine production is functionally related to the reduced lymphocyte proliferation in atopic dermatitis,” The Journal of Allergy and Clinical Immunology, vol. 97, no. 1, pp. 85–94, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. F. T. Liu, H. Goodarzi, and H. Y. Chen, “IgE, mast cells, and eosinophils in atopic dermatitis,” Clinical Reviews in Allergy and Immunology, vol. 41, no. 3, pp. 298–310, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Boguniewicz and D. Y. M. Leung, “Atopic dermatitis: a disease of altered skin barrier and immune dysregulation,” Immunological Reviews, vol. 242, no. 1, pp. 233–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Heilmann, “Adhesion mechanisms of staphylococci,” Advances in Experimental Medicine and Biology, vol. 715, pp. 105–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Kaesler, T. Volz, Y. Skabytska et al., “Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10,” The Journal of Allergy and Clinical Immunology, vol. 134, no. 1, pp. 92–99.e6, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. S.-H. Cho, I. Strickland, A. Tomkinson, A. P. Fehringer, E. W. Gelfand, and D. Y. M. Leung, “Preferential binding of Staphylococcus aureus to skin sites of Th2-mediated inflammation in a murine model,” The Journal of Investigative Dermatology, vol. 116, no. 5, pp. 658–663, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. S.-H. Cho, I. Strickland, M. Boguniewicz, and D. Y. M. Leung, “Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin,” The Journal of Allergy and Clinical Immunology, vol. 108, no. 2, pp. 269–274, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Imokawa, A. Abe, K. Jin, Y. Higaki, M. Kawashima, and A. Hidano, “Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?” The Journal of Investigative Dermatology, vol. 96, no. 4, pp. 523–526, 1991. View at Publisher · View at Google Scholar
  35. J. Ishikawa, H. Narita, N. Kondo et al., “Changes in the ceramide profile of atopic dermatitis patients,” The Journal of Investigative Dermatology, vol. 130, no. 10, pp. 2511–2514, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J. van Smeden and J. A. Bouwstra, “Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients,” Current Problems in Dermatology, vol. 49, pp. 8–26, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. M. H. Meckfessel and S. Brandt, “The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products,” Journal of the American Academy of Dermatology, vol. 71, no. 1, pp. 177–184, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Ohnishi, N. Okino, M. Ito, and S. Imayama, “Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis,” Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 1, pp. 101–104, 1999. View at Google Scholar
  39. M. Mempel, T. Schmidt, S. Weidinger et al., “Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay,” The Journal of Investigative Dermatology, vol. 111, no. 3, pp. 452–456, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Christophers and T. Henseler, “Contrasting disease patterns in psoriasis and atopic dermatitis,” Archives of Dermatological Research, vol. 279, no. S1, pp. S48–S51, 1987. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Frasca and R. Lande, “Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases,” Current Pharmaceutical Biotechnology, vol. 13, no. 10, pp. 1882–1897, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. K. A. Brogden, “Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?” Nature Reviews Microbiology, vol. 3, no. 3, pp. 238–250, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Reinholz, T. Ruzicka, and J. Schauber, “Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease,” Annals of Dermatology, vol. 24, no. 2, pp. 126–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Marcinkiewicz and S. Majewski, “The role of antimicrobial peptides in chronic inflammatory skin diseases,” Advances in Dermatology and Allergology, vol. 33, no. 1, pp. 6–12, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. P. Y. Ong, T. Ohtake, C. Brandt et al., “Endogenous antimicrobial peptides and skin infections in atopic dermatitis,” The New England Journal of Medicine, vol. 347, no. 15, pp. 1151–1160, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Albanesi, H. R. Fairchild, S. Madonna et al., “IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3,” Journal of Immunology, vol. 179, no. 2, pp. 984–992, 2007. View at Publisher · View at Google Scholar
  47. M. Niebuhr, “Infections and bacterial colonization including treatment,” in Atopic Dermatitis in Childhood and Adolescence, T. Werfel, J. M. Spergel, and W. Kiess, Eds., Karger, Basel, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Salgado-Pabon, L. C. Case-Cook, and P. M. Schlievert, “Molecular analysis of staphylococcal superantigens,” Methods in Molecular Biology, vol. 1085, pp. 169–185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Saline, K. E. J. Rödström, G. Fischer, V. Y. Orekhov, B. G. Karlsson, and K. Lindkvist-Petersson, “The structure of superantigen complexed with TCR and MHC reveals novel insights into superantigenic T cell activation,” Nature Communications, vol. 1, no. 8, p. 119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Akiyama, Y. Toi, H. Kanzaki, J. Tada, and J. Arata, “Prevalence of producers of enterotoxins and toxic shock syndrome toxin-1 among Staphylococcus aureus strains isolated from atopic dermatitis lesions,” Archives of Dermatological Research, vol. 288, no. 7, pp. 418–420, 1996. View at Publisher · View at Google Scholar
  51. J. P. Mcfadden, W. C. Noble, and R. D. R. Camp, “Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin,” The British Journal of Dermatology, vol. 128, no. 6, pp. 631-632, 1993. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Bunikowski, M. E. A. Mielke, H. Skarabis et al., “Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis,” The Journal of Allergy and Clinical Immunology, vol. 105, no. 4, pp. 814–819, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. T. M. Zollner, T. A. Wichelhaus, A. Hartung et al., “Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis,” Clinical and Experimental Allergy, vol. 30, no. 7, pp. 994–1000, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. C. Motala, P. Potter, E. Weinberg, D. Malherbe, and J. Hughes, “Anti-specific IgE in atopic dermatitis,” The Journal of Allergy and Clinical Immunology, vol. 78, no. 4, pp. 583–589, 1986. View at Publisher · View at Google Scholar · View at Scopus
  55. K. Reginald, K. Westritschnig, T. Werfel et al., “Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients,” Clinical and Experimental Allergy, vol. 41, no. 3, pp. 357–369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. G. R. Bessa, V. P. Quinto, D. C. Machado et al., “Staphylococcus aureus resistance to topical antimicrobials in atopic dermatitis,” Anais Brasileiros de Dermatologia, vol. 91, no. 5, pp. 604–610, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Schnopp, J. Ring, and M. Mempel, “The role of antibacterial therapy in atopic eczema,” Expert Opinion on Pharmacotherapy, vol. 11, no. 6, pp. 929–936, 2010. View at Publisher · View at Google Scholar · View at Scopus